0001415889-17-000663.txt : 20170421 0001415889-17-000663.hdr.sgml : 20170421 20170421123842 ACCESSION NUMBER: 0001415889-17-000663 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170421 DATE AS OF CHANGE: 20170421 EFFECTIVENESS DATE: 20170421 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AzurRx BioPharma, Inc. CENTRAL INDEX KEY: 0001604191 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-285301 FILM NUMBER: 17774841 BUSINESS ADDRESS: STREET 1: 760 PARKSIDE AVENUE STREET 2: SUITE 304 CITY: BROOKLYN STATE: NY ZIP: 11226 BUSINESS PHONE: 646-699-7855 MAIL ADDRESS: STREET 1: 760 PARKSIDE AVENUE STREET 2: SUITE 304 CITY: BROOKLYN STATE: NY ZIP: 11226 FORMER COMPANY: FORMER CONFORMED NAME: BioPharma d'Azur, Inc. DATE OF NAME CHANGE: 20140331 D 1 primary_doc.xml X0707 D LIVE 0001604191 AzurRx BioPharma, Inc. 760 Parkside Avenue Suite 304 Brooklyn NY NEW YORK 11226 646-699-7855 DELAWARE None BioPharma d'Azur, Inc. Corporation true 2014 Johan (Thijs) Spoor c/o AzurRx BioPharma, Inc. 760 Parkside Avenue, Suite 304 Brooklyn NY NEW YORK 11226 Executive Officer Director Edward Borkowski c/o AzurRx BioPharma, Inc. 760 Parkside Avenue, Suite 304 Brooklyn NY NEW YORK 11226 Director Alastair Riddell c/o AzurRx BioPharma, Inc. 760 Parkside Avenue, Suite 304 Brooklyn NY NEW YORK 11226 Director Maged Shenouda c/o AzurRx BioPharma, Inc. 760 Parkside Avenue, Suite 304 Brooklyn NY NEW YORK 11226 Director Charles Casamento c/o AzurRx BioPharma, Inc. 760 Parkside Avenue, Suite 304 Brooklyn NY NEW YORK 11226 Director Biotechnology No Revenues 06b false 2017-04-09 false true true false 1000000 1000000 1000000 0 false 0 1 0 0 0 true Company requires short-term working capital to fund certain operating costs. AzurRx BioPharma, Inc. /s/ Johan M. (Thijs) Spoor Johan M. (Thijs) Spoor President and CEO 2017-04-21